JP2009543794A5 - - Google Patents

Download PDF

Info

Publication number
JP2009543794A5
JP2009543794A5 JP2009519603A JP2009519603A JP2009543794A5 JP 2009543794 A5 JP2009543794 A5 JP 2009543794A5 JP 2009519603 A JP2009519603 A JP 2009519603A JP 2009519603 A JP2009519603 A JP 2009519603A JP 2009543794 A5 JP2009543794 A5 JP 2009543794A5
Authority
JP
Japan
Prior art keywords
compound according
carbon atoms
compound
alkyl
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009519603A
Other languages
English (en)
Japanese (ja)
Other versions
JP5532302B2 (ja
JP2009543794A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/072917 external-priority patent/WO2008008701A2/en
Publication of JP2009543794A publication Critical patent/JP2009543794A/ja
Publication of JP2009543794A5 publication Critical patent/JP2009543794A5/ja
Application granted granted Critical
Publication of JP5532302B2 publication Critical patent/JP5532302B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009519603A 2006-07-10 2007-07-06 治療化合物 Expired - Fee Related JP5532302B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US80681306P 2006-07-10 2006-07-10
US60/806,813 2006-07-10
PCT/US2007/072917 WO2008008701A2 (en) 2006-07-10 2007-07-06 Substituted cyclopentane derivatives as therapeutic agents

Publications (3)

Publication Number Publication Date
JP2009543794A JP2009543794A (ja) 2009-12-10
JP2009543794A5 true JP2009543794A5 (https=) 2010-08-26
JP5532302B2 JP5532302B2 (ja) 2014-06-25

Family

ID=38740285

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009519603A Expired - Fee Related JP5532302B2 (ja) 2006-07-10 2007-07-06 治療化合物

Country Status (8)

Country Link
US (2) US7605178B2 (https=)
EP (1) EP2069295B1 (https=)
JP (1) JP5532302B2 (https=)
AU (1) AU2007272683B2 (https=)
BR (1) BRPI0714709A2 (https=)
CA (1) CA2657625C (https=)
ES (1) ES2447065T3 (https=)
WO (2) WO2008008700A2 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008008700A2 (en) * 2006-07-10 2008-01-17 Allergan, Inc. Substituted cyclopentane derivatives as therapeutic agents
JP5570807B2 (ja) * 2006-07-11 2014-08-13 アラーガン インコーポレイテッド 抗緑内障薬としてのシクロペンタン誘導体
RU2010103149A (ru) 2007-07-03 2011-08-10 Аллерган, Инк. (Us) Терапевтические замещенные циклопентаны для уменьшения внутриглазного давления
US7947732B2 (en) * 2007-07-13 2011-05-24 Allergan, Inc. Therapeutic substituted chlorocyclopentanols
US8592413B2 (en) 2008-05-15 2013-11-26 Allergan, Inc. Therapeutic substituted cyclopentanes
US8252788B2 (en) 2008-05-20 2012-08-28 Allergan, Inc. Therapeutic compounds
EP2300412A1 (en) 2008-05-27 2011-03-30 Allergan, Inc. Prostaglandin produgs as hypotensive agents
ES2693255T3 (es) 2014-02-27 2018-12-10 Ono Pharmaceutical Co., Ltd. Compuesto que presenta actividad agonista de EP2 selectiva
EP3152188B1 (en) * 2014-06-06 2019-02-13 Allergan, Inc. Novel ep4 agonists as therapeutic compounds
US10385045B2 (en) 2015-07-23 2019-08-20 Ono Pharmaceutical Co., Ltd. Compound having EP2 agonist activity

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3980700A (en) 1971-10-07 1976-09-14 G. D. Searle & Co. Prostaglandin intermediates and optically active isomers thereof
DE2256537A1 (de) 1972-11-17 1974-10-10 Merck Patent Gmbh Neue sulfide
US4073799A (en) 1975-02-27 1978-02-14 (Zaidanhojin) Sagami Chemical Research Center Process for producing 3-formylcyclopentanone derivatives
JPS51110557A (en) 1975-03-26 1976-09-30 Sagami Chem Res Rakutonsurufuidono seizohoho
US4094886A (en) 1976-03-01 1978-06-13 (Zaidanhojin) Sagami Chemical Research Center Process for producing allyl alcohol derivatives useful in prostaglandin synthesis
US4166452A (en) 1976-05-03 1979-09-04 Generales Constantine D J Jr Apparatus for testing human responses to stimuli
US4256108A (en) 1977-04-07 1981-03-17 Alza Corporation Microporous-semipermeable laminated osmotic system
HU180705B (hu) 1978-07-13 1983-04-29 Chinoin Gyogyszer Es Vegyeszet Eljárás új 4-ariltiometil-2H-ciklopentano[b]furán-származékok előállítására
US4265874A (en) 1980-04-25 1981-05-05 Alza Corporation Method of delivering drug with aid of effervescent activity generated in environment of use
HU191196B (hu) 1982-04-09 1987-01-28 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt,Hu Eljárás új ariltió-klórmetil-c1klopentán-származékok előállítására
JP2943306B2 (ja) 1990-10-12 1999-08-30 住友化学工業株式会社 シクロペンタンアルデヒド類およびその製造法
AU7349298A (en) 1997-06-23 1999-01-04 Pfizer Inc. Prostaglandin agonists
JP2001527063A (ja) * 1998-12-24 2001-12-25 小野薬品工業株式会社 ω−シクロアルキル−プロスタグランジンＥ２誘導体
EP1108426A3 (en) 1999-12-02 2002-10-02 Pfizer Products Inc. Use of prostaglandin agonists to treat erectile dysfunction or impotence
US6291522B1 (en) * 2000-09-27 2001-09-18 Allergan Sales, Inc. Cyclopentane heptan(ENE)oic acid, 2-thiocarbamoyloxy and 2-carbamoyloxy compounds as therapeutic agents
CA2454422A1 (en) * 2001-07-31 2003-02-13 Ryuji Ueno Treatment of ocular hypertension and glaucoma
JP4149153B2 (ja) * 2001-09-28 2008-09-10 富士フイルム株式会社 ポジ型レジスト組成物
US7235586B2 (en) * 2003-09-09 2007-06-26 Allergan, Inc. Cyclopentane heptan(ene)oic acid, 2-thiocarbamoyloxy and 2-carbamoyloxy compounds as therapeutic agents
ATE465986T1 (de) * 2005-01-14 2010-05-15 Allergan Inc Substituierte cyclopentane oder cyclopentanone zur behandlung von augenhochdruck
PL212658B1 (pl) * 2005-04-18 2012-11-30 Inst Farmaceutyczny Sposób otrzymywania pochodnych 13,14-dihydro-PGF<sub>2</sub><sub>α</sub>
US7323591B2 (en) * 2006-01-10 2008-01-29 Allergan, Inc. Substituted cyclopentanes or cyclopentanones as therapeutic agents
US7439372B2 (en) 2006-05-03 2008-10-21 Allergan, Inc. Therapeutic compounds
US7491844B2 (en) 2006-05-04 2009-02-17 Allergan, Inc. Therapeutic cyclopentane derivatives
US7547727B2 (en) 2006-05-22 2009-06-16 Allergan, Inc. Therapeutic cyclopentane derivatives
US7429669B2 (en) * 2006-06-20 2008-09-30 Allergan, Inc. Therapeutic compounds
WO2008008700A2 (en) * 2006-07-10 2008-01-17 Allergan, Inc. Substituted cyclopentane derivatives as therapeutic agents
US20080015219A1 (en) * 2006-07-11 2008-01-17 Allergan, Inc. Therapeutic compounds
US7507817B2 (en) * 2006-11-17 2009-03-24 Allergan, Inc. Prostaglandin prodrugs
CA2675981A1 (en) * 2007-01-22 2008-07-31 Allergan, Inc. Thiophene derivatives useful as ocular hypotensive agents

Similar Documents

Publication Publication Date Title
JP2009543794A5 (https=)
JP2009543795A5 (https=)
JP2009541340A5 (https=)
JP2009543792A5 (https=)
JP2010500416A5 (https=)
JP2010500976A5 (https=)
JP2009540009A5 (https=)
JP2013537203A5 (https=)
WO2008008718B1 (en) Cyclopentane derivatives as antiglaucoma agents
EP2414328A2 (en) Dihydroorotate dehydrogenase inhibitors
JP2010526025A5 (https=)
JP2009535307A5 (https=)
DK3009426T3 (en) 4-ALKYNYL-IMIDAZOLE DERIVATIVE AND MEDICINE COMPREHENSIVE AS AN ACTIVE INGREDIENT
WO2006098918B1 (en) Substituted gamma lactams as therapeutic agents
JP2009535426A5 (https=)
KR20120104077A (ko) 리바록사반 및 그 중간생성물의 제조방법
JP2014508811A5 (https=)
JP2013505929A5 (https=)
JP2009527501A5 (https=)
JPWO2012102255A1 (ja) インドール誘導体、またはその薬理学的に許容される塩
JP2010504286A5 (https=)
WO2008008701B1 (en) Substituted cyclopentane derivatives as therapeutic agents
JP2011500818A5 (https=)
JP2012502048A5 (https=)
WO2008008660B1 (en) Cyclopentane derivatives as antiglaucoma agents